Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1052

1.

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient.

Crimini E, Roberto M, Degli Effetti V, Marchetti P, Botticelli A, Schipilliti FM, Arrivi G, Mazzuca F.

Case Rep Oncol Med. 2019 Mar 28;2019:2507642. doi: 10.1155/2019/2507642. eCollection 2019.

2.

What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.

Cortellini A, Porzio G, Cofini V, Necozione S, Giusti R, Marchetti P, Aloe Spiriti MA, Costanzi A, Peris F, Ravoni G, Spinelli G, Ficorella C, Verna L.

J Oncol Pharm Pract. 2019 May 1:1078155219843161. doi: 10.1177/1078155219843161. [Epub ahead of print]

PMID:
31042135
3.

[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]

Giusti R, Verna L, Porzio G, Marchetti P.

Recenti Prog Med. 2019 Mar;110(3):115-117. doi: 10.1701/3132.31137. Italian.

PMID:
30968850
4.

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab.

De Giorgi U, Procopio G, Giannarelli D, Sabbatini R, Bearz A, Buti S, Basso U, Mitterer M, Ortega C, Bidoli P, Ferraù F, Crinò L, Frassoldati A, Marchetti P, Mini E, Scoppola A, Verusio C, Fornarini G, Cartenì G, Caserta C, Sternberg CN.

Clin Cancer Res. 2019 Apr 9. doi: 10.1158/1078-0432.CCR-18-3661. [Epub ahead of print]

PMID:
30967420
5.

The Italian Rare Pancreatic Exocrine Cancer Initiative.

Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N.

Tumori. 2019 Apr 9:300891619839461. doi: 10.1177/0300891619839461. [Epub ahead of print]

PMID:
30967031
6.

Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes.

Khamis A, Canouil M, Siddiq A, Crouch H, Falchi M, Bulow MV, Ehehalt F, Marselli L, Distler M, Richter D, Weitz J, Bokvist K, Xenarios I, Thorens B, Schulte AM, Ibberson M, Bonnefond A, Marchetti P, Solimena M, Froguel P.

Mol Metab. 2019 Mar 18. pii: S2212-8778(19)30130-9. doi: 10.1016/j.molmet.2019.03.004. [Epub ahead of print]

7.

Impact of tumor site on the prognosis of small bowel adenocarcinoma.

Falcone R, Romiti A, Filetti M, Roberto M, Righini R, Botticelli A, Pilozzi E, Ghidini M, Pizzo C, Mazzuca F, Marchetti P.

Tumori. 2019 Apr 1:300891619839297. doi: 10.1177/0300891619839297. [Epub ahead of print]

PMID:
30935289
8.

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.

Capalbo C, Scafetta G, Filetti M, Marchetti P, Bartolazzi A.

Int J Mol Sci. 2019 Mar 31;20(7). pii: E1607. doi: 10.3390/ijms20071607.

9.

Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets.

D'Arcangelo D, Scatozza F, Giampietri C, Marchetti P, Facchiano F, Facchiano A.

Cancers (Basel). 2019 Mar 29;11(4). pii: E446. doi: 10.3390/cancers11040446.

10.

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.

Botticelli A, Salati M, Di Pietro FR, Strigari L, Cerbelli B, Zizzari IG, Giusti R, Mazzotta M, Mazzuca F, Roberto M, Vici P, Pizzuti L, Nuti M, Marchetti P.

J Transl Med. 2019 Mar 27;17(1):99. doi: 10.1186/s12967-019-1847-x.

11.

Study of histopathologic parameters to define the prognosis of stage II colon cancer.

Romiti A, Roberto M, Marchetti P, Di Cerbo A, Falcone R, Campisi G, Ferri M, Balducci G, Ramacciato G, Ruco L, Pilozzi E.

Int J Colorectal Dis. 2019 May;34(5):905-913. doi: 10.1007/s00384-019-03279-1. Epub 2019 Mar 26.

PMID:
30915540
12.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

Cortellini A, Chiari R, Ricciuti B, Metro G, Perrone F, Tiseo M, Bersanelli M, Bordi P, Santini D, Giusti R, Grassadonia A, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Iacono D, Migliorino MR, Porzio G, Cannita K, Ficorella C, Buti S.

Clin Lung Cancer. 2019 Feb 21. pii: S1525-7304(19)30025-7. doi: 10.1016/j.cllc.2019.02.006. [Epub ahead of print]

PMID:
30885550
13.

Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets.

Sacco F, Seelig A, Humphrey SJ, Krahmer N, Volta F, Reggio A, Marchetti P, Gerdes J, Mann M.

Cell Metab. 2019 Mar 7. pii: S1550-4131(19)30076-2. doi: 10.1016/j.cmet.2019.02.012. [Epub ahead of print]

PMID:
30879985
14.

Modulation of Autophagy Influences the Function and Survival of Human Pancreatic Beta Cells Under Endoplasmic Reticulum Stress Conditions and in Type 2 Diabetes.

Bugliani M, Mossuto S, Grano F, Suleiman M, Marselli L, Boggi U, De Simone P, Eizirik DL, Cnop M, Marchetti P, De Tata V.

Front Endocrinol (Lausanne). 2019 Feb 26;10:52. doi: 10.3389/fendo.2019.00052. eCollection 2019.

15.

Mitochondrial activity as an indicator of fish freshness.

Cléach J, Pasdois P, Marchetti P, Watier D, Duflos G, Goffier E, Lacoste AS, Slomianny C, Grard T, Lencel P.

Food Chem. 2019 Jul 30;287:38-45. doi: 10.1016/j.foodchem.2019.02.076. Epub 2019 Feb 23.

PMID:
30857714
16.

Insulin secretory granules labelled with phogrin-fluorescent proteins show alterations in size, mobility and responsiveness to glucose stimulation in living β-cells.

Ferri G, Digiacomo L, Lavagnino Z, Occhipinti M, Bugliani M, Cappello V, Caracciolo G, Marchetti P, Piston DW, Cardarelli F.

Sci Rep. 2019 Feb 27;9(1):2890. doi: 10.1038/s41598-019-39329-5.

17.

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.

Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F, Giusti R, Tiseo M, Michiara M, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Rastelli F, Pergolesi F, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, De Giglio A, Iacono D, Gelibter A, Occhipinti MA, Parisi A, Porzio G, Fargnoli MC, Ascierto PA, Ficorella C, Natoli C.

J Immunother Cancer. 2019 Feb 27;7(1):57. doi: 10.1186/s40425-019-0527-y.

18.

Coxsackievirus B Tailors the Unfolded Protein Response to Favour Viral Amplification in Pancreatic β Cells.

Colli ML, Paula FM, Marselli L, Marchetti P, Roivainen M, Eizirik DL, Op de Beeck A.

J Innate Immun. 2019 Feb 20:1-15. doi: 10.1159/000496034. [Epub ahead of print]

19.

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.

Cortellini A, Buti S, Santini D, Perrone F, Giusti R, Tiseo M, Bersanelli M, Michiara M, Grassadonia A, Brocco D, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Sabbatini R, Bracarda S, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, Iacono D, Migliorino MR, Rossi A, Porzio G, Cannita K, Ciciarelli V, Fargnoli MC, Ascierto PA, Ficorella C.

Oncologist. 2019 Feb 22. pii: theoncologist.2018-0618. doi: 10.1634/theoncologist.2018-0618. [Epub ahead of print]

PMID:
30796151
20.

Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.

Rossi M, Casale G, Badiali D, Aielli F, Aloe Spiriti MA, Arcioni R, Bordin F, Ferrara M, Morelli Sbarra G, Corcione A, Marinangeli F, Marchetti P.

Support Care Cancer. 2019 Feb 18. doi: 10.1007/s00520-019-04688-2. [Epub ahead of print]

PMID:
30778756

Supplemental Content

Loading ...
Support Center